BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35151012)

  • 21. Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh, Saudi Arabia.
    Sheshah E; Sabico S; Albakr RM; Sultan AA; Alghamdi KS; Al Madani K; Alotair HA; Al-Daghri NM
    Diabetes Res Clin Pract; 2021 Feb; 172():108538. PubMed ID: 33189790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.
    Alsofayan YM; Althunayyan SM; Khan AA; Hakawi AM; Assiri AM
    J Infect Public Health; 2020 Jul; 13(7):920-925. PubMed ID: 32534945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection].
    Troldborg A; Bartels LE; Deleuran B
    Ugeskr Laeger; 2020 May; 182(20):. PubMed ID: 32400380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19).
    Chen CP; Lin YC; Chen TC; Tseng TY; Wong HL; Kuo CY; Lin WP; Huang SR; Wang WY; Liao JH; Liao CS; Hung YP; Lin TH; Chang TY; Hsiao CF; Huang YW; Chung WS; Cheng CY; Cheng SH;
    PLoS One; 2020; 15(12):e0242763. PubMed ID: 33264337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and treatment outcomes of severe (ICU) COVID-19 patients in Saudi Arabia: A single centre study.
    Alghamdi S
    Saudi Pharm J; 2021 Oct; 29(10):1096-1101. PubMed ID: 34366685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "H" is not for hydroxychloroquine-"H" is for heparin: lack of efficacy of hydroxychloroquine and the role of heparin in COVID-19-preliminary data of a prospective and interventional study from Brazil.
    de Oliveira Costa R; Nascimento JS; Reichert CO; da Costa APA; Dos Santos MAP; Soares AM; Tomé CEM; Hayden RL; Dos Santos CW; Barreiro B; El-Khatib AAB; de Pádua Covas Lage LA; Pereira J; Benetti MM
    BMC Infect Dis; 2022 Feb; 22(1):120. PubMed ID: 35120461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
    Liu Y; Fu X; Xie C
    Medicine (Baltimore); 2020 Sep; 99(37):e22031. PubMed ID: 32925737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study.
    Saib A; Amara W; Wang P; Cattan S; Dellal A; Regaieg K; Nahon S; Nallet O; Nguyen LS
    PLoS One; 2021; 16(6):e0252388. PubMed ID: 34106964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
    Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
    Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
    Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
    J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors associated with in-hospital mortality patients with COVID-19 in Saudi Arabia.
    Aljuaid M; Alotair H; Alnajjar F; Alonazi W; Sharaf H; Sheshah E; Alashgar L; Alshaikh M
    PLoS One; 2022; 17(6):e0270062. PubMed ID: 35749537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial.
    Stoll F; Blank A; Mikus G; Czock D; Foerster KI; Hermann S; Häußler K; Muhareb A; Hummler S; Weiss J; Burhenne J; Haefeli WE
    Trials; 2020 Jun; 21(1):584. PubMed ID: 32600363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perception and attitude of healthcare workers in Saudi Arabia with regard to Covid-19 pandemic and potential associated predictors.
    Abolfotouh MA; Almutairi AF; BaniMustafa AA; Hussein MA
    BMC Infect Dis; 2020 Sep; 20(1):719. PubMed ID: 32993538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering.
    Di Castelnuovo A; Gialluisi A; Antinori A; Berselli N; Blandi L; Bonaccio M; Bruno R; Cauda R; Costanzo S; Guaraldi G; Menicanti L; Mennuni M; My I; Parruti G; Patti G; Perlini S; Santilli F; Signorelli C; Stefanini G; Vergori A; Ageno W; Agodi A; Agostoni P; Aiello L; Al Moghazi S; Arboretti R; Aucella F; Barbieri G; Barchitta M; Bonfanti P; Cacciatore F; Caiano L; Cannata F; Carrozzi L; Cascio A; Castiglione G; Ciccullo A; Cingolani A; Cipollone F; Colomba C; Colombo C; Crisetti A; Crosta F; Danzi GB; D'Ardes D; de Gaetano Donati K; Di Gennaro F; Di Tano G; D'Offizi G; Fusco FM; Gaudiosi C; Gentile I; Gianfagna F; Giuliano G; Graziani E; Guarnieri G; Langella V; Larizza G; Leone A; Maccagni G; Magni F; Maitan S; Mancarella S; Manuele R; Mapelli M; Maragna R; Marcucci R; Maresca G; Marongiu S; Marotta C; Marra L; Mastroianni F; Mengozzi A; Meschiari M; Milic J; Minutolo F; Mussinelli R; Mussini C; Musso M; Odone A; Olivieri M; Palimodde A; Pasi E; Pesavento R; Petri F; Pivato CA; Poletti V; Ravaglia C; Righetti G; Rognoni A; Rossato M; Rossi I; Rossi M; Sabena A; Salinaro F; Sangiovanni V; Sanrocco C; Schiano Moriello N; Scorzolini L; Sgariglia R; Simeone PG; Spinicci M; Tamburrini E; Torti C; Trecarichi EM; Vettor R; Vianello A; Vinceti M; Virdis A; De Caterina R; Iacoviello L
    J Healthc Eng; 2021; 2021():5556207. PubMed ID: 34336157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.